Follow-up from the #PITVIN Study showed the risk of long-term recurrence of #vulvar HSIL does not differ significantly between primary treatment with imiquimod or surgical treatment.

Highlights are summarised below ⬇️ and full paper link: bit.ly/4dyBu5r

#IPVSPaperoftheWeek